Vera Therapeutics | DEFA14A: Others
Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Joseph R
Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grant Sean
Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grant Sean
Vera Therapeutics | ARS: Annual Report to Security Holders
Vera Therapeutics | DEF 14A: Definitive information statements
Vera Therapeutics | DEFA14A: Others
Vera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Vera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Vera Therapeutics | 10-K: Annual report
Vera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dr. Maha Katabi (“Katabi”)(5.4%),Sofinnova Venture Partners X, L.P. (“SVP X”)(5.3%), etc.
Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Katabi Maha
Vera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Vera Therapeutics | 8-K: Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Vera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%), etc.
Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(11.3%),Commodore Capital Master LP(11.3%)
Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(12.3%),Commodore Capital Master LP(12.3%)
Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Securities LLC(0.1%),Citadel Securities Group LP(0.1%), etc.
Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ares Trading SA(3.6%),Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany(3.6%), etc.
Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(8.22%),Kynam Capital Management GP, LLC(8.22%), etc.
No Data